GEN Exclusives

More »

GEN News Highlights

More »
Nov 9, 2010

Sapio Sciences to Supply LIMS to University of British Columbia

  • Sapio Sciences has entered into an agreement to supply the University of British Columbia’s Center for Molecular Medicine and Therpeutics (CMMT) Next Gen Sequencing Lab with its Exemplar Laboratory Information Management Solution (LIMS).

    CMMT plans to utilize Exemplar LIMS for sample management and integration with robotic platforms. The Examplar LIMS will support remote web-based sample submission and processing requests and automate storage management of samples, Sapio notes. Moreover, it will integrate with various laboratory devices to automate control of quantitation and hit-picking experiments, retrieve DNA extraction information, and implement workflows for genotyping and sequencing, the firm adds.

    “Exemplar excels at rapid implementation of instrument integrations, which can be combined with Examplar’s configurable ELN capability for a complete workflow that has automated instrument control and data capture,” says Julia Neel, chief software architect at Sapio.

    The University of British Columbia’s CMMT was founded in 1995 and explores the genetic basis of disease. It endeavors to translate what they learn into new treatment strategies for common and neglected diseases.

Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Easing Restrictions for Terminal Patients

Should the Federal Government Pass a “Right to Try” Bill Allowing Terminally Ill Patients Access to Experimental Medicines?

More »